2Saito K. Low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor for the treatment of relapsed acute myeloid leukemia. Rinsho Ketsueki, 1996, 37:651-653.
3Bai A, Kojima H, Hori M, et al. Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells. Exp Hematol, 1999,27:259-265.
2[1]Sasaki K, Murakami T, Takanashi M. A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine. Cytometry, 1987,8(5): 526
3[2]Dolbear F, Gratzner HG, Pallavicini MG et al. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA, 1983, 80(18): 5573
4[3]Ohtake N, Kanzaki T, Nakano R. Differentiation of malignant lymphoma and non-lymphoma by an occlusive dressing method. J Dermatol, 1999,26(9):549
5[4]Mazzotti G, Gobbi P, Manzoli L et al. Nuclear morphology during the S phase. Microsc Res Tech, 1998,40(5):418
6[5]Grebenova D, Cajthamlova H, Bartosova J et al. Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin-IX. J Photochem Photobiol B, 1998, 47(1): 74
7[6]Dipietro R, Centurione L, Santavenere E et al. Ionizing rediation-induced apoptosis and DNA repair in murine erythroleukemia cells. Scanning Microsc,1996,10(1):253
8[7]Preisler HD, Raza A. Cell cycle studies in acute myelogenous leukemia. Leukemia,1992, 6(8): 751
8Lyman GH,Kuderer NM,Djulbegovic B.Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy:a meta-analysis[J].Am J Med,2002,112(5):406-411.
9Foon RA, ZigheboimJ, Yale C,et al. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia [J]. Blood, 1981;58 (5): 467-468
10Brito-Babapulle F, CatovskyD, slocombe G, et al. Phase Ⅱ study of mitoxantrone and cyarabine in elderly patients with acute myelogenous leukemia [J]. Blood, 1987, 26 (8):132-133
